Global Cholera Vaccines Market Research and Forecast Report 2022-2027
© 2019 IMARC All Rights Reserved
Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group
About IMARC Group
Report Description
The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights
Report Description
Cholera Vaccines Market Research Report: According to the latest report by IMARC Group, titled “ Cholera Vaccines Market Report 2022, Industry Overview, Size, Share, Growth, Trends Analysis And F orecast 2027 ,” the global cholera vaccines market reached a strong growth in 2021. Cholera is a bacterial infection caused by the bacterium Vibrio Cholera that spreads through the contaminated food and water consumption. It is an intestinal disease that exhibits the symptoms of severe diarrhea, abdominal pain, muscle cramps, dry mucus, and dehydration, which may lead to death in extreme cases. As a result, it is essential to control cholera through vaccination, available in the form of inactivated and live oral cholera vaccines. Cholera vaccine is particularly administered to travelers and people living in cholera affected areas, which helps develop immunity against the disease. Request Free Sample Report: https://www.imarcgroup.com/cholera-vaccines-market/requestsample
Report Description and Highlights
Report Description
Global Cholera Vaccines Market Trends : The global cholera vaccines market is primarily driven by the increasing prevalence of cholera worldwide as it is deemed a global threat to public health, especially in regions lacking social development. Besides this, the growing awareness regarding the lack of proper sanitation and the adverse effects of consuming contaminated food are also fueling the cholera vaccines market growth. In addition, governments in various countries are implementing initiatives to support cholera preventive care by focusing on immunization programs and extensively investing in developing novel cholera vaccines. Furthermore, non-governmental organizations (NGOs) are increasing awareness about cholera to reduce vaccine-preventable diseases. Moreover, the rising research and development (R&D) activities to enhance the efficacy and cost-effectiveness of vaccines is further expected to propel the market growth in the upcoming years. Looking forward, the market value is projected to reach a strong growth during the forecast period (2022-2027).
Report Description and Highlights
Report Description Market Summary:
Market Breakup by Vaccine Type: • Whole Cell V. Cholerae O1 with Recombinant B-Subunit • Killed Oral O1 and O139 Market Breakup by Product: • Dukoral • Shanchol • Vaxchora • Euvichol and Euvichol-Plus • Others Market Breakup by End User: • Hospitals and Clinics • Research and Academic Laboratories • Others
Report Description and Highlights Report Description Market Breakup by Region: • North America • United States • Canada • Asia Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others
Report Description and Highlights Report Description • Latin America • Brazil • Mexico • Others • Middle East and Africa Turkey Note: We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report. View Full Report with TOC & List of Figure: https://www.imarcgroup.com/cholera-vaccines-market
A partial List of
We are the trusted business partners to the
Clients world's leading corporates, governments, and ourPartial ClientsList of institutions
A partial List of
We are the trusted business partners to the
of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions
Report Description and Highlights
Report Description
© 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us
FOR MORE DETAILS Visit us at :
https://www.imarcgroup.com Stay With Us:
TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com